help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Enjalbert, A.
Right arrow Articles by Heisler, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Enjalbert, A.
Right arrow Articles by Heisler, S.

Endocrinology, Vol 123, 406-412, Copyright © 1988 by Endocrine Society


ARTICLES

Dopamine inhibits prolactin secretion stimulated by the calcium channel agonist Bay-K-8644 through a pertussis toxin-sensitive G protein in anterior pituitary cells

A Enjalbert, F Musset, C Chenard, M Priam, C Kordon and S Heisler
Unite de Neuroendocrinologie, INSERM U. 159, Centre Paul Broca, Paris, France.

In primary culture of anterior pituitary cells, BAY-K-8644, a calcium channel agonist, stimulated PRL secretion by 83% with EC50 of 18 nM. This effect was blocked by nifedipine, a calcium channel antagonist. The stimulations of PRL secretion induced by potassium (50 mM) and BAY- K-8644 were additive. Dopamine inhibited basal as well as BAY-K-8644- stimulated PRL secretion by 64% and 75%, respectively, and with respective EC50 values of 4.5 and 0.6 nM. In the presence of 50 mM K+, dopamine only partially blocks the dose-dependent stimulation of PRL secretion induced by the calcium channel agonist. The inhibitory dopamine effect was blocked by (+)butaclamol, a specific dopamine receptor antagonist. The dopamine response was also blocked by 1- sulpiride, a specific dopamine D2 receptor antagonist, and mimicked by RU 24926, a specific dopamine D2 receptor agonist, suggesting that the dopamine effect on BAY-K-8644-stimulated PRL secretion was mediated through a D2 dopamine receptor. Although unknown, the mechanism by which dopamine inhibited the BAY-K-8644-stimulated PRL secretion involves a GTP binding protein sensitive to Bordetella pertussis toxin. In fact, the dopamine inhibition of PRL secretion induced by the calcium channel agonist was blocked by the pretreatment of cells with the toxin. These results suggest that dopamine D2 receptors in lactotroph cells modulate calcium influx through a GTP binding protein.


This article has been cited by other articles:


Home page
J EndocrinolHome page
H. L Henderson, J. Townsend, and D. J Tortonese
Direct effects of prolactin and dopamine on the gonadotroph response to GnRH
J. Endocrinol., May 1, 2008; 197(2): 343 - 350.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. E. Gonzalez-Iglesias, T. Murano, S. Li, M. Tomic, and S. S. Stojilkovic
Dopamine Inhibits Basal Prolactin Release in Pituitary Lactotrophs through Pertussis Toxin-Sensitive and -Insensitive Signaling Pathways
Endocrinology, April 1, 2008; 149(4): 1470 - 1479.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. K. Sarkar, K. Chaturvedi, S. Oomizu, N. I. Boyadjieva, and C. P. Chen
Dopamine, Dopamine D2 Receptor Short Isoform, Transforming Growth Factor (TGF)-{beta}1, and TGF-{beta} Type II Receptor Interact to Inhibit the Growth of Pituitary Lactotropes
Endocrinology, October 1, 2005; 146(10): 4179 - 4188.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. Ben-Jonathan and R. Hnasko
Dopamine as a Prolactin (PRL) Inhibitor
Endocr. Rev., December 1, 2001; 22(6): 724 - 763.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. A. Gregerson, T. P. Flagg, T. J. O'Neill, M. Anderson, O. Lauring, J. S. Horel, and P. A. Welling
Identification of G Protein-Coupled, Inward Rectifier Potassium Channel Gene Products from the Rat Anterior Pituitary Gland
Endocrinology, July 1, 2001; 142(7): 2820 - 2832.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society